UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the Month of August 2026
CAMTEK LTD.
(Translation of Registrant’s Name into English)
Ramat Gavriel Industrial Zone
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange
Act of 1934.
Yes ☐ No ☒
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form
6-K, including all exhibits hereto, is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933.
| |
|
CAMTEK LTD.
(Registrant)
By: /s/ Moshe Eisenberg
——————————————
Moshe Eisenberg,
Chief Financial Officer
|
Dated: August 10, 2026
|
|
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: Info@camtek.com Web site: http://www.camtek.com
|
|
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
moshee@camtek.com
|
INTERNATIONAL INVESTOR RELATIONS
EK Global Investor Relations
Ehud Helft
Tel: (US) 1 212 378 8040
camtek@ekgir.com
|
|
FOR IMMEDIATE RELEASE
CAMTEK ANNOUNCES RESULTS
FOR THE SECOND QUARTER OF 2026
Q2 record revenues of $133.2 million; Expects more than 30% growth in H2-26 vs. H1-26 and
further growth into 2027
MIGDAL HAEMEK, Israel – August 10, 2026 – Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced its financial results for the second quarter ended June 30,
2026.
2026 Second Quarter Financial Highlights
|
• |
Record revenues of $133.2 million, a 10% QoQ increase;
|
|
• |
GAAP gross margin of 50.1% and non-GAAP gross margin of 51.4%;
|
|
• |
GAAP operating income of $27.2 million and non-GAAP operating income of $36.0 million, representing operating margins of 20.4% and 27%, respectively;
|
|
• |
GAAP net income of $23.3 million and non-GAAP net income of $39.4 million; GAAP diluted EPS of $0.46 and non-GAAP diluted EPS of $0.78; and
|
|
• |
Completed the Visual Layer acquisition
|
Forward-Looking Expectations
Management expects third-quarter revenue to be in the range of $158 million to $160 million, representing an exceptional 20% sequential increase over the second quarter.
Given our strong order momentum and record backlog, management expects more than 30% growth in H2-26 vs. H1-26 followed by continued growth into 2027.
Management Comment
Rafi Amit, Camtek’s CEO commented, “I am very pleased with the second quarter results which set a record revenue for us. Since the beginning of 2026, we have
experienced a significant acceleration in order intake, bringing total orders received year-to-date to more than $600 million, with deliveries scheduled throughout the remainder of 2026 and into 2027.
This exceptional level of order intake, combined with our leadership position in the Advanced Packaging (AP) segment, has significantly improved our business visibility and is expected to drive a
very strong second half, with our AP revenue to grow approximately 70% between the first and fourth quarters of 2026.
Concluded Mr. Amit, “Our product development roadmap is closely aligned with the technology roadmaps of the industry's leading customers. Combined with our deep customer
engagement, expanding product portfolio, and proven execution, positions us to penetrate new process steps and applications, giving us strong confidence in our ability to deliver sustained growth in the years ahead.”
Second Quarter 2026 Financial Results
Revenues for the second quarter of 2026 were $133.2 million. This compares to second quarter 2025 revenues of $123.3 million, a year-over-year growth of 8%.
Gross profit on a GAAP basis in the quarter totaled $66.7 million (50.1% of revenues), an increase of 7% compared to $62.6 million (50.8% of revenues) in the
second quarter of 2025.
Gross profit on a non-GAAP basis in the quarter totaled $68.5 million (51.4% of revenues), an increase of 7% compared to $64.0 million (51.9% of revenues) in
the second quarter of 2025.
Operating income on a GAAP basis in the quarter totaled $27.2 million (20.4% of revenues), a decrease of 15% compared to $32.0 million (25.9% of revenues) in
the second quarter of 2025.
Operating income on a non-GAAP basis in the quarter totaled $36.0 million (27.0% of revenues), a decrease of 4% compared to $37.4 million (30.3% of revenues)
in the second quarter of 2025.
Net income on a GAAP basis in the quarter totaled $23.3 million, or $0.46 per diluted share, a decrease of 31% compared to net income of $33.7 million, or
$0.69 per diluted share, in the second quarter of 2025.
Net income on a non-GAAP basis in the quarter totaled $39.4 million, or $0.78 per diluted share, an increase of 2% compared to a non-GAAP net income of $38.8
million, or $0.79 per diluted share, in the second quarter of 2025.
Cash and cash equivalents, short-term and long-term deposits, and marketable securities, as of June 30, 2026, were $815.8 million compared to $849.7 million
as of March 31, 2026. During the second quarter, the Company generated an operating cash flow of $12.2 million.
Conference Call
Camtek will host a video conference call/webinar today via Zoom, on August 10, 2026, at 09:00 ET (16:00 Israel time). Rafi Amit, CEO, Moshe Eisenberg, CFO, and Ramy Langer, COO will host the call and
will be available to answer questions after presenting the results.
To participate in the webinar, please register using the following link, which will provide access to the video call:
https://us06web.zoom.us/webinar/register/WN_a_Na02dbSo-7hZ5je-P39g
For those wishing to listen via phone, following registration, the dial in link will be sent. For any problems in registering, please email Camtek’s investor relations a few hours in advance of the
call.
For those unable to participate, a recording will be available on Camtek’s website at http://www.camtek.com within a few hours after the call.
A summary presentation of the quarterly results will also be available on Camtek’s website.
ABOUT CAMTEK LTD.
Camtek is a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry. Camtek's systems inspect IC and measure IC features on wafers throughout the
production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly (Post Dicing). Camtek's systems inspect wafers for the most demanding semiconductor market segments, including Advanced Interconnect
Packaging, Heterogenous Integration, Memory and HBM, CMOS Image Sensors, Compound Semiconductors, MEMS, and RF, serving numerous industries’ leading global IDMs, OSATs, and foundries.
With manufacturing facilities in Israel and Germany, and eight offices around the world, Camtek provides state of the art solutions in line with customers' requirements.
This press release is available at http://www.camtek.com
This press release contains statements that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements are based on Camtek’s current beliefs, expectations and assumptions about its business and industry, all of which may change. Forward-looking statements can be identified by the use of words including “believe,”
“anticipate,” “should,” “intend,” “plan,” “will,” “may,” “expect,” “estimate,” “project,” “positioned,” “strategy,” and similar expressions that are intended to identify forward-looking statements, including our expectations and statements
relating to our future earnings and guidance, the compound semiconductors market and our position in this market. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or
achievements of Camtek to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause our actual results to differ materially from those contained in
the forward-looking statements include, but are not limited to, risks related to the ongoing hostilities in the Middle East; the impact of disruptions to global shipment and supply chain, including but
not limited to increased risk and disruption around the Strait of Hormuz, and broader impacts on energy and freight markets; the continued demand and future contribution of HBM and Chiplet applications and devices to the Company business
resulting from, among other things, the field of AI surging worldwide across companies, industries and nations; formal or informal imposition by countries of new or revised export and/or import and
doing-business regulations or sanctions, including but not limited to changes in U.S. trade policies, changes or uncertainty related to the U.S. government entity list and changes in the ability to sell products incorporating U.S originated
technology, which can be made without prior notice, and our ability to effectively address such global trade issues and changes; risks related to fluctuations in foreign currency exchange rates; and those other factors discussed in our Annual
Report on Form 20-F as published on March 19, 2026, as well as other documents filed by the Company with the SEC as well as other documents that may be subsequently filed by Camtek from time to time with the Securities and Exchange Commission. We
caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Camtek does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may
arise after the date of this release unless required by law.
While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a
combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Camtek’s views only as of the date of this press release and should not
be relied upon as representing its views as of any subsequent date. Camtek does not assume any obligation to update any forward-looking statements unless required by law.
This press release provides financial measures that exclude: (i) share based compensation expenses; (ii) acquisition related expenses and (iii) one-time tax expenses and are
therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance. The presentation of this
non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business
internally and therefore felt it is important to make these non-GAAP adjustments available to investors. A reconciliation between the GAAP and non-GAAP results appears in the tables at the end of this press release. The results reported in this
press-release are preliminary unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.
CAMTEK LTD. and its subsidiaries
Condensed Interim Consolidated Balance Sheets (Unaudited)
(In thousands)
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
Assets
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
215,229
|
|
|
|
177,848
|
|
|
Short-term deposits
|
|
|
327,440
|
|
|
|
411,450
|
|
|
Marketable securities
|
|
|
87,695
|
|
|
|
78,862
|
|
|
Trade accounts receivable, net
|
|
|
153,921
|
|
|
|
90,829
|
|
|
Inventories
|
|
|
99,816
|
|
|
|
112,202
|
|
|
Other current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Marketable securities
|
|
|
185,473
|
|
|
|
182,941
|
|
|
Long-term inventory
|
|
|
16,979
|
|
|
|
15,569
|
|
|
Deferred tax asset, net
|
|
|
11,661
|
|
|
|
12,933
|
|
|
Other assets, net
|
|
|
1,802
|
|
|
|
1,881
|
|
|
Property, plant and equipment, net
|
|
|
59,359
|
|
|
|
55,090
|
|
|
Right of use assets, net
|
|
|
9,968
|
|
|
|
10,017
|
|
|
Intangible assets, net
|
|
|
16,654
|
|
|
|
10,062
|
|
|
Goodwill
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total non-current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ equity
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
Trade accounts payable
|
|
|
48,402
|
|
|
|
33,676
|
|
|
Other current liabilities
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
125,338
|
|
|
|
107,425
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term liabilities
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities, net
|
|
|
-
|
|
|
|
1,261
|
|
|
Other long-term liabilities
|
|
|
15,054
|
|
|
|
14,311
|
|
|
Convertible notes
|
|
|
|
|
|
|
|
|
|
Total long-term liabilities
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
|
|
|
|
|
|
|
|
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2026 and at December 31, 2025;
|
|
|
|
|
|
|
|
|
|
48,760,553 issued shares at June 30, 2026 and 47,920,509 at December 31, 2025;
|
|
|
|
|
|
|
|
|
|
46,668,177 shares outstanding at June 30, 2026 and 45,828,133 at December 31, 2025
|
|
|
181
|
|
|
|
178
|
|
|
Additional paid-in capital
|
|
|
272,741
|
|
|
|
231,892
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
(2,355
|
)
|
|
|
287
|
|
|
Retained earnings
|
|
|
|
|
|
|
|
|
| |
|
|
712,061
|
|
|
|
618,901
|
|
|
Treasury stock, at cost (2,092,376 shares as of June 30, 2026 and December 31, 2025)
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total shareholders' equity
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity
|
|
|
|
|
|
|
|
|
CAMTEK LTD. and its subsidiaries
Condensed Interim Consolidated Statement of Income (unaudited)
(in thousands)
| |
|
Six months ended
June 30,
|
|
|
Three months
ended June 30,
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
254,902
|
|
|
|
241,955
|
|
|
|
133,243
|
|
|
|
123,317
|
|
|
|
496,072
|
|
|
Cost of revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
31,007
|
|
|
|
21,836
|
|
|
|
16,684
|
|
|
|
11,474
|
|
|
|
48,345
|
|
|
Selling, general and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
73,138
|
|
|
|
58,501
|
|
|
|
39,475
|
|
|
|
30,637
|
|
|
|
122,114
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial income, net
|
|
|
15,126
|
|
|
|
10,375
|
|
|
|
6,977
|
|
|
|
4,942
|
|
|
|
25,064
|
|
|
Other expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share information:
|
|
|
Six months ended
June 30,
|
|
|
Three months
ended June 30,
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
Basic net earnings per share (in US dollars)
|
|
|
1.18
|
|
|
|
1.49
|
|
|
|
0.50
|
|
|
|
0.74
|
|
|
|
1.11
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings per share (in US dollars)
|
|
|
1.09
|
|
|
|
1.39
|
|
|
|
0.46
|
|
|
|
0.69
|
|
|
|
1.04
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ordinary shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
46,496
|
|
|
|
45,622
|
|
|
|
46,643
|
|
|
|
45,682
|
|
|
|
45,703
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
51,433
|
|
|
|
49,306
|
|
|
|
51,520
|
|
|
|
49,327
|
|
|
|
49,970
|
|
CAMTEK LTD. and its subsidiaries
Reconciliation of GAAP To Non-GAAP results
(In thousands, except share data)
| |
|
Six Months ended
June 30,
|
|
|
Three Months ended
June 30,
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
Reported net income attributable to Camtek Ltd. on GAAP basis
|
|
|
54,950
|
|
|
|
68,006
|
|
|
|
23,305
|
|
|
|
33,695
|
|
|
|
50,722
|
|
|
Acquisition-related expenses (1)
|
|
|
4,059
|
|
|
|
1,300
|
|
|
|
3,570
|
|
|
|
650
|
|
|
|
2,801
|
|
|
One-time Tax expenses
|
|
|
7,700
|
|
|
|
-
|
|
|
|
7,700
|
|
|
|
-
|
|
|
|
-
|
|
|
Loss from extinguishment of Capital Notes (2)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
88,682
|
|
|
Share-based compensation
|
|
|
7,995
|
|
|
|
8,203
|
|
|
|
4,873
|
|
|
|
4,493
|
|
|
|
16,819
|
|
|
Non-GAAP net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non–GAAP net income per diluted share
|
|
|
1.48
|
|
|
|
1.57
|
|
|
|
0.78
|
|
|
|
0.79
|
|
|
|
3.26
|
|
|
Gross margin on GAAP basis
|
|
|
50.1
|
%
|
|
|
50.9
|
%
|
|
|
50.1
|
%
|
|
|
50.8
|
%
|
|
|
50.4
|
%
|
|
Reported gross profit on GAAP basis
|
|
|
127,631
|
|
|
|
123,175
|
|
|
|
66,702
|
|
|
|
62,611
|
|
|
|
250,317
|
|
|
Acquisition-related expenses (1)
|
|
|
1,707
|
|
|
|
1,220
|
|
|
|
1,097
|
|
|
|
610
|
|
|
|
2,895
|
|
|
Share-based compensation
|
|
|
1,139
|
|
|
|
1,344
|
|
|
|
687
|
|
|
|
763
|
|
|
|
2,806
|
|
|
Non- GAAP gross profit
|
|
|
130,477
|
|
|
|
125,739
|
|
|
|
68,486
|
|
|
|
63,984
|
|
|
|
256,018
|
|
|
Non-GAAP gross margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported operating income attributable to Camtek Ltd. on GAAP basis
|
|
|
54,493
|
|
|
|
64,674
|
|
|
|
27,227
|
|
|
|
31,974
|
|
|
|
128203
|
|
|
Acquisition-related expenses (1)
|
|
|
4,620
|
|
|
|
1,856
|
|
|
|
3,928
|
|
|
|
928
|
|
|
|
4,000
|
|
|
Share-based compensation
|
|
|
7,995
|
|
|
|
8,203
|
|
|
|
4,873
|
|
|
|
4,493
|
|
|
|
16,819
|
|
|
Non-GAAP operating income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) During the six-month period ended June 30, 2026, the Company recorded acquisition-related expenses of $1.3 million, consisting of: (1) inventory written-up to fair value in purchase
accounting charges of $0.5 million. This amount is recorded under cost of revenues line item. (2) $1.2 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $0.2 million of compensation-related expenses
recorded under research and development expenses line item. (4) $0.1 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (5) $2.6 million one-time M&A expenses recorded under G&A line
item. (6) $0.6 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.
During the three-month period ended June 30, 2026, the Company recorded acquisition-related expenses of $0.8 million, consisting of: (1) inventory written-up to fair value in purchase accounting
charges of $0.5 million. This amount is recorded under cost of revenues line item. (2) $0.6 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $0.2 million of compensation-related expenses recorded
under research and development expenses line item. (4) $0.1 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (5) $2.6 million one-time M&A expenses recorded under G&A line item. (6)
$0.4 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.
During the six-month period ended June 30, 2025, the Company recorded acquisition-related expenses of $1.3 million, consisting of: (1) $1.2 million amortization of intangible assets acquired
recorded under cost of revenues line item. (2) $0.6 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (3) $0.6 million reversal of tax provision related to the above adjustment, recorded under
the tax expense line item.
During the three-month period ended June 30, 2025, the Company recorded acquisition-related expenses of $0.6 million, consisting of: (1) $0.6 million amortization of intangible assets acquired
recorded under cost of revenues line item. (2) $0.3 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (3) $0.3 million reversal of tax provision related to the above adjustment, recorded under
the tax expense line item.
During the year ended December 31, 2025, the Company recorded acquisition-related expenses of $2.8 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of
$0.5 million. This amount is recorded under cost of revenues line item. (2) $2.4 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $1.1 million amortization of intangible assets acquired recorded
under sales and marketing expenses line item. (4) $1.2 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.
(2) During the year ended December 31, 2025, the Company recorded a loss of $88.7 million, consisting of: (1) $100.9 million from the extinguishment of Capital Notes recorded under the
other expenses line item. (2) $12.3 million tax benefit recorded under the income tax benefit line item.